glp-1 pharma Novo, Lilly buoyed by fast-growing drug sales Ease your GLP As GLP-1 Use Expands, Long-Term

Supplementation is often recommended during pregnancy and lactation

Tirzepatide (weekly injectable) Dosing frequency: Once weekly, same day each week Half-life: approximately 5 days (120 hours) Peak concentration: 8 to 72 hours after injection Recommended timing approach: The shorter half-life compared to semaglutide means the end-of-week trough is more noticeable

Combination therapies in CKD associated with T2D RAAS inhibitors are recommended for patients with T2D who are at high risk of developing CKD or CKD progression, with or without comorbid hypertension, especially in the presence of albuminuria [6, 18, 20]

Each of the main types of injection (intravenous, intramuscular, intradermal and subcutaneous) have a number of disadvantages, which will help the healthcare professional choose the most appropriate injection technique to use based on the patient and type of product to administer